The information on this page about Zidolam-N Tablet – Zidovudine + Lamivudine + Nevirapine is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
Zidolam-N Tablet is a prescription-only antiretroviral medicine used as part of doctor-prescribed HIV treatment (ART) for HIV-1 infection and must be taken only under the supervision of a qualified healthcare professional. Do not self-medicate, change the dose, skip doses, or stop treatment without medical advice.
Always inform your doctor about your medical history, liver conditions, blood-related concerns, allergies and any medicines you take. Zidolam-N Tablet does not cure HIV/AIDS and should be used with regular medical monitoring as prescribed by your doctor.
Medically reviewed by qualified clinicians at TAAL+ Healthcare. Last reviewed: May 2026.
Consultant in HIV Prevention, Sexual Wellness & LGBTQ+ Health
Specialization: HIV Prevention (PrEP), STI & STD, LGBTQ+ Health
Experience: Over 18 years in healthcare, HIV prevention research, transgender health programs, and clinical care
Last Updated: May 2026
Zidolam-N Tablet is a Schedule H prescription-only antiretroviral medicine containing Zidovudine + Lamivudine + Nevirapine, used as part of combination antiretroviral therapy (ART) for HIV-1 infection. Because this medicine may require regular treatment monitoring and liver function assessment, it should only be taken under medical supervision and exactly as prescribed by your doctor.